GlassScriptPhysician profile
Mahdi S Abdullah
NPI 1285601914
$2,444.71
in general payments reported to CMS, 2019-2025
21 companies · $538 in 2025
The $538 reported for 2025 was more than what 75% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $270 · 2021: $126 · 2022: $392 · 2023: $771 · 2024: $107 · 2025: $538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,416.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $626.47 | 2019-2025 | Collagenase Santyl, Regranex, Iodosorb Ointment 40g USA |
| Bayer Healthcare Pharmaceuticals INC. | $416.29 | 2022-2023 | |
| Integra Lifesciences Corporation | $179.88 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Bioventus LLC | $177.77 | 2022-2023 | |
| Gilead Sciences, INC. | $156.56 | 2020-2023 | |
| Organogenesis INC. | $144.72 | 2020-2021 | |
| Novo Nordisk INC | $122.83 | 2025 | Ozempic |
| Stryker Corporation | $108.57 | 2023 | Surpass Evolve |
| Misonix INC | $73.92 | 2019-2020 | |
| Solventum Corporation | $64.21 | 2025 | Activ.A.C., Promogran Prisma |
| Kerecis Limited | $60.31 | 2019-2022 | |
| Abbvie INC. | $59.14 | 2024-2025 | |
| Averitas Pharma INC. | $49.10 | 2025 | Qutenza |
| Novartis Pharmaceuticals Corporation | $34.02 | 2019-2021 | |
| Eisai INC. | $32.58 | 2020-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $32.21 | 2025 | Dexcom G6 Transmitter |
| Lifenet Health | $25.49 | 2023 | |
| Kci USA, INC. | $24.28 | 2022 | |
| Abbott Laboratories | $22.86 | 2025 | Freestyle Libre 3 |
| Tei Medical INC. | $21.91 | 2019 | |
| Medline Industries LP | $11.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mahdi Abdullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.